Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Feiba 500IU


May be acceptable
If it is considered to be clearly essential

Contraindicated
Feiba 500IU :
Type Medicine Authorised
Originator B
Agent Abela Freres
Distributor Abela Freres
Laboratory Baxter
Responsible Party Baxter AG
Origin Austria
Manufacturer Takeda Austria GmbH
Origin Austria
ATC B02BD03

Your comment will appear shortly after approval

Feiba 500IU :

Revision Date : 01/01/2002


Effect Frequency
Allergic reaction Uncommon
Anaphylaxis Rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Uncommon
Chest tightness Uncommon
Chills Uncommon
Factor IX inhibition Rare
Fever Rare
Flushing Uncommon
Headache Uncommon
Hives Uncommon
Hypersensitivity reactions Uncommon
Hypotension Uncommon
Infusion site burning Uncommon
Infusion site stinging Uncommon
Lethargy Uncommon
Nausea Uncommon
Nephrotic syndrome Rare
Restlessness Uncommon
Tachycardia Uncommon
Tingling Uncommon
Urticaria generalised Uncommon
Vomiting Uncommon
Wheezing Uncommon

Different Units By MoH Code

Feiba 500IU  MoH 10367 :
Form Powder and solvent for solution for injection/infusion
Packaging Bottle
Package Size 1+1x10ml
Strength 500IU
Public Price 619968 L.L.
Stratum E1
NSSF ✘
Quarantine ✘
Reg. Number 83920/1
Submission date 30/08/2020
Registration Year 17/09/2020


Price Comparison

● Country: The Netherlands
● Package Size: 1
● Public Price: 802.7 EUR ( 77,762,365.20 LBP )
● Pack size unit used: 1
● Cost/Unit: 802,7 EUR ( 77,694,552.00 LBP )
● Pharmacy Price: 795.7 EUR ( 77084233.2 LBP )
● Reference: Zorginstituut Nederland
● Pricing Date: 21/09/2020
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 1+1x20 ml
● Public Price: 1959 AED ( 47,331,399.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 1959 AED ( 47,331,399.00 LBP )
● Pharmacy Price: 1669.12 AED ( 40327608.32 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: UAE
● Package Size: 1+1x20 ml
● Public Price: 1959 AED ( 47,331,399.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 1959 AED ( 47,331,399.00 LBP )
● Pharmacy Price: 1669.12 AED ( 40327608.32 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: Oman
● Package Size: 500U/10ml
● Public Price: 202.42 OMR ( 46,705,176.28 LBP )
● Pack size unit used: 1
● Cost/Unit: 202,42 OMR ( 46,608,268.00 LBP )
● Pricing Date: 19/02/2021
● Type: Medicine Authorised

● Country: UK
● Package Size: 1
● Public Price: 390 GBP ( 44,323,110.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 390 GBP ( 44,323,110.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Authorised

● Country: Spain
● Package Size: 1 vial + 1xdisolvente
● Public Price: 455.61 EUR ( 44,137,674.36 LBP )
● Pack size unit used: 1
● Cost/Unit: 455,61 EUR ( 44,078,580.00 LBP )
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Non Marketed

● Country: Czech Republic
● Package Size: 1X500U+10ml+BAXJECT
● Public Price: 11147.23 CZK ( 42,571,271.37 LBP )
● Pack size unit used: 1
● Cost/Unit: 11147,23 CZK ( 42,570,393.00 LBP )
● Reference: SUKL
● Pricing Date: 28/02/2020
● Type: Medicine Authorised

● Country: Norway
● Package Size: 1
● Public Price: 5088.6 NOK ( 41,238,014.40 LBP )
● Pack size unit used: 1
● Cost/Unit: 5088,6 NOK ( 41,233,152.00 LBP )
● Pharmacy Price: 3962.66 NOK ( 32113396.64 LBP )
● Reference: Norwegian Medicine Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: KSA
● Package Size: 20ml
● Public Price: 1645.3 SAR ( 38,894,892.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 1645,3 SAR ( 38,887,800.00 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

● Country: Greece
● Package Size: 1
● Public Price: 401.69 EUR ( 38,914,120.44 LBP )
● Pack size unit used: 1
● Cost/Unit: 401,69 EUR ( 38,847,276.00 LBP )
● Exfactory Price: 339.4 EUR
● Pharmacy Price: 344.5 EUR ( 33373782 LBP )
● Reference: National Organization for Medicines
● Pricing Date: 22/10/2017
● Type: Medicine Authorised

● Country: Sweden
● Package Size: 1
● Public Price: 3961.01 SEK ( 33,304,172.08 LBP )
● Pack size unit used: 1
● Cost/Unit: 3961,01 SEK ( 33,304,088.00 LBP )
● Pharmacy Price: 3838 SEK ( 32269904 LBP )
● Pricing Date: 23/04/2020
● Type: Medicine Authorised

● Country: Turkey
● Package Size: 1
● Public Price: 3206.36 TRY ( 8,593,044.80 LBP )
● Pack size unit used: 1
● Cost/Unit: 3206,36 TRY ( 8,592,080.00 LBP )
● Pricing Date: 28/10/2020
● Type: Medicine Authorised

● Country: Lebanon
● Form: Powder and solvent for solution for injection/infusion
● Package Size: 1+1x10ml
● Public Price: 619968 LBP ( 619,968.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 619968 LBP ( 619,968.00 LBP )
● Pricing Date: 13/06/2024

● Country: France
● Package Size: 1+1x10 ml
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: New Zealand
● Package Size: 1 inj
● Exfactory Price: 1315 NZD
● Reference: New Zealand Pharmaceutical Management Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
● Cost/Unit: 802,7 EUR ( 77,694,552.00 LBP )
● Cost/Day: EUR ( 0.00 LBP )
● Cost/Month: EUR ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
● Cost/Unit: 802,7 EUR ( 77,694,552.00 LBP )
● Cost/Day: EUR ( 0.00 LBP )
● Cost/Month: EUR ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
● Cost/Unit: 802,7 EUR ( 77,694,552.00 LBP )
● Cost/Day: EUR ( 0.00 LBP )
● Cost/Month: EUR ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
● Cost/Unit: 1959 AED ( 47,331,399.00 LBP )
● Cost/Day: AED ( 0.00 LBP )
● Cost/Month: AED ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
● Cost/Unit: 1959 AED ( 47,331,399.00 LBP )
● Cost/Day: AED ( 0.00 LBP )
● Cost/Month: AED ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
● Cost/Unit: 1959 AED ( 47,331,399.00 LBP )
● Cost/Day: AED ( 0.00 LBP )
● Cost/Month: AED ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
● Cost/Unit: 1959 AED ( 47,331,399.00 LBP )
● Cost/Day: AED ( 0.00 LBP )
● Cost/Month: AED ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
● Cost/Unit: 1959 AED ( 47,331,399.00 LBP )
● Cost/Day: AED ( 0.00 LBP )
● Cost/Month: AED ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
● Cost/Unit: 1959 AED ( 47,331,399.00 LBP )
● Cost/Day: AED ( 0.00 LBP )
● Cost/Month: AED ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
● Cost/Unit: 202,42 OMR ( 46,608,268.00 LBP )
● Cost/Day: OMR ( 0.00 LBP )
● Cost/Month: OMR ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
● Cost/Unit: 202,42 OMR ( 46,608,268.00 LBP )
● Cost/Day: OMR ( 0.00 LBP )
● Cost/Month: OMR ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
● Cost/Unit: 202,42 OMR ( 46,608,268.00 LBP )
● Cost/Day: OMR ( 0.00 LBP )
● Cost/Month: OMR ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
● Cost/Unit: 390 GBP ( 44,323,110.00 LBP )
● Cost/Day: GBP ( 0.00 LBP )
● Cost/Month: GBP ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
● Cost/Unit: 390 GBP ( 44,323,110.00 LBP )
● Cost/Day: GBP ( 0.00 LBP )
● Cost/Month: GBP ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
● Cost/Unit: 390 GBP ( 44,323,110.00 LBP )
● Cost/Day: GBP ( 0.00 LBP )
● Cost/Month: GBP ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
● Cost/Unit: 455,61 EUR ( 44,078,580.00 LBP )
● Cost/Day: EUR ( 0.00 LBP )
● Cost/Month: EUR ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
● Cost/Unit: 455,61 EUR ( 44,078,580.00 LBP )
● Cost/Day: EUR ( 0.00 LBP )
● Cost/Month: EUR ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
● Cost/Unit: 455,61 EUR ( 44,078,580.00 LBP )
● Cost/Day: EUR ( 0.00 LBP )
● Cost/Month: EUR ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
● Cost/Unit: 11147,23 CZK ( 42,570,393.00 LBP )
● Cost/Day: CZK ( 0.00 LBP )
● Cost/Month: CZK ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
● Cost/Unit: 11147,23 CZK ( 42,570,393.00 LBP )
● Cost/Day: CZK ( 0.00 LBP )
● Cost/Month: CZK ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
● Cost/Unit: 11147,23 CZK ( 42,570,393.00 LBP )
● Cost/Day: CZK ( 0.00 LBP )
● Cost/Month: CZK ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
● Cost/Unit: 5088,6 NOK ( 41,233,152.00 LBP )
● Cost/Day: NOK ( 0.00 LBP )
● Cost/Month: NOK ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
● Cost/Unit: 5088,6 NOK ( 41,233,152.00 LBP )
● Cost/Day: NOK ( 0.00 LBP )
● Cost/Month: NOK ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
● Cost/Unit: 5088,6 NOK ( 41,233,152.00 LBP )
● Cost/Day: NOK ( 0.00 LBP )
● Cost/Month: NOK ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
● Cost/Unit: 1645,3 SAR ( 38,887,800.00 LBP )
● Cost/Day: SAR ( 0.00 LBP )
● Cost/Month: SAR ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
● Cost/Unit: 1645,3 SAR ( 38,887,800.00 LBP )
● Cost/Day: SAR ( 0.00 LBP )
● Cost/Month: SAR ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
● Cost/Unit: 1645,3 SAR ( 38,887,800.00 LBP )
● Cost/Day: SAR ( 0.00 LBP )
● Cost/Month: SAR ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
● Cost/Unit: 401,69 EUR ( 38,847,276.00 LBP )
● Cost/Day: EUR ( 0.00 LBP )
● Cost/Month: EUR ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
● Cost/Unit: 401,69 EUR ( 38,847,276.00 LBP )
● Cost/Day: EUR ( 0.00 LBP )
● Cost/Month: EUR ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
● Cost/Unit: 401,69 EUR ( 38,847,276.00 LBP )
● Cost/Day: EUR ( 0.00 LBP )
● Cost/Month: EUR ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
● Cost/Unit: 3961,01 SEK ( 33,304,088.00 LBP )
● Cost/Day: SEK ( 0.00 LBP )
● Cost/Month: SEK ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
● Cost/Unit: 3961,01 SEK ( 33,304,088.00 LBP )
● Cost/Day: SEK ( 0.00 LBP )
● Cost/Month: SEK ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
● Cost/Unit: 3961,01 SEK ( 33,304,088.00 LBP )
● Cost/Day: SEK ( 0.00 LBP )
● Cost/Month: SEK ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
● Cost/Unit: 3206,36 TRY ( 8,592,080.00 LBP )
● Cost/Day: TRY ( 0.00 LBP )
● Cost/Month: TRY ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
● Cost/Unit: 3206,36 TRY ( 8,592,080.00 LBP )
● Cost/Day: TRY ( 0.00 LBP )
● Cost/Month: TRY ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
● Cost/Unit: 3206,36 TRY ( 8,592,080.00 LBP )
● Cost/Day: TRY ( 0.00 LBP )
● Cost/Month: TRY ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
● Cost/Unit: 619968 LBP ( 619,968.00 LBP )
● Cost/Day: LBP ( 0.00 LBP )
● Cost/Month: LBP ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
● Cost/Unit: 619968 LBP ( 619,968.00 LBP )
● Cost/Day: LBP ( 0.00 LBP )
● Cost/Month: LBP ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
● Cost/Unit: 619968 LBP ( 619,968.00 LBP )
● Cost/Day: LBP ( 0.00 LBP )
● Cost/Month: LBP ( 0.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info